SCEMBLIX

Identification of Scemblix

No description

Google image searchProduct monograph

Active ingredient

asciminib (asciminib hydrochloride), 20 MG

DIN: 02528320

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 01-SEP-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EA — BCR-ABL tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EA06 — ASCIMINIB (ATC/DDD)

Reference brand drug: Scemblix

External Links for Scemblix

Search on Google

• Scemblix side effects
• Scemblix dosage
• asciminib side effects
• asciminib dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find scemblix photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.